B

BenevolentAI

404 employees

BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.

Basic info

Industry

biotechnology research

Sectors

Engineering
Biotechnology
Scientific Innovation
Artificial Intelligence
Big Data
Bioscience
Pharmaceutical
Drug Development
Machine Learning
Deep Learning

Date founded

2013

Funding rounds raised

Total raised

$115M

from 5 investors over 5 rounds

B

BenevolentAI raised $90M on September 17, 2019

Investors: Temasek

B

BenevolentAI raised $115M on April 19, 2018

Investors: Woodford Investment Management

B

BenevolentAI raised $87M on August 26, 2015

Investors: Upsher-Smith Laboratories, Lansdowne Partners and Woodford Investment Management

FAQ